Company intelligence / Profile preview

Life Seal Vascular

Costa Mesa, California, United States

Ownership: Private
Development stage: Other

Overview

Life Seal Vascular has received NSF SBIR funding to support further development of its CYGNUM aneurysm sac management device, designed as an adjunct to EVAR to eliminate endoleaks, reduce reinterventions, and improve aortic aneurysm outcomes. Clinical results have not yet been published, technology is in pre-commercial grant-funded development.[1][2][3]

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Life Seal Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Life Seal Vascular.

Explore the full profile